title: Erythrocytosis: the HIF pathway in control.
abstract: Organisms living under aerobic conditions need oxygen for the metabolic conversion of nutrition into energy. With the appearance of increasingly complex animals, a specialized transport system (erythrocytes) arose during evolution to provide oxygen to virtually every single cell in the body. Moreover, in case of low environmental partial pressure of oxygen, the number of erythrocytes automatically increases to preserve sustained oxygen delivery. This process relies predominantly on the cytokine erythropoietin (Epo) and its transcription factor hypoxia inducible factor (HIF), whereas the von Hippel-Lindau (VHL) ubiquitin ligase as well as the oxygen-sensitive prolyl hydroxylases (PHDs) represent essential regulators of this oxygen-sensing system. Deregulation of particular members of this pathway (eg, PHD2, HIF2α, VHL) lead to disorders in blood homeostasis as a result of insufficient (anemia) or excessive (erythrocytosis) red blood cell production.
authors.affiliation: Emmy Noether Research Group, Institute of Pathology, University of Technology, Dresden, Germany.
authors.forename: Kristin
authors.initials: K
authors.lastname: Franke
authors.forename: Max
authors.initials: M
authors.lastname: Gassmann
authors.forename: Ben
authors.initials: B
authors.lastname: Wielockx
mesh_terms: D000818:Animals; D006801:Humans; D051793:Hypoxia-Inducible Factor 1 / Q000378:metabolism*; D011086:Polycythemia / Q000378:metabolism* / Q000473:pathology*; D015398:Signal Transduction
chemical_list: D051793:Hypoxia-Inducible Factor 1